Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors.
Document Type
Journal Article
Publication Date
7-9-2019
Journal
Journal of Hematology & Oncology
Volume
12
Issue
1
DOI
10.1186/s13045-019-0761-2
APA Citation
Li, W., Gupta, S., Han, W., Kundson, R., Nelson, S., Knutson, D., Greipp, P., Elsawa, S., Sotomayor, E., & Gupta, M. (2019). Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors.. Journal of Hematology & Oncology, 12 (1). http://dx.doi.org/10.1186/s13045-019-0761-2
Peer Reviewed
1
Open Access
1